Clinique Louis Pasteur

Esseylesnancy 54270

0 studies enrolling now · 2 studies all time

What they study most

CLL, Relapsed/Refractory Follicular Non-Hodgkin Lymphoma

Studies at this site

• Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL) — Running, not enrolling
• A Study Comparing Obinutuzumab and BGB-3111 Versus Obinutuzumab Alone in Treating R/R Follicular Lymphoma — Completed